Formulation and Characterization of Alginate Microbeads of Clonidine Hydrochloride by Ionotropic Gelation Technique
The objective of this study was to prepare and evaluate sodium alginate microbeads with calcium chloride as cross-linking agent for Clonidine hydrochloride by ionotropic gelation method. Clonidine hydrochloride a centrally acting sympatholytic and imidazoline-derivative hypotensive agent; selective α2-adrenergic agonist. It stimulates alpha2-adrenergic receptors in the brainstem to decrease sympathetic nervous system outflow. It is also administered epidurally to treat pain. Microbeads offer numerous advantages for releasing one of the drugs or part of the same drug immediately while remaining drug or parts of the same can be sustained release. Prepared microbeads were evaluated for particle size, polydispersity index, zeta potential, particle shape, surface morphology, entrapment efficiency and In vitro drug release. The prepared beads were free flowing and white in color. The drug loaded beads showed 72.9±2.4% to 94.6±2.6 % drug entrapment, which was found to increase with increase in alginate concentration. In vitro drug release study of these microbeads indicated controlled release for Clonidine hydrochloride 83.46% release after 48 hours. Hence the observations of all results of the different batches, MBD 11 showed controlled release action and improved drug availability. From this study it could be concluded that the free flowing microbeads of Clonidine hydrochloride could be successfully prepared by ionotropic gelation technique with high entrapment efficiency and prolonged release characteristics.
Keywords: Clonidine hydrochloride, Microbeads, Sodium alginate, Calcium chloride, Ionotropic gelation method.
2. Pillay V, Fassihi R. In-vitro release modulation from cross linked pellets for site-specific drug delivery to the gastrointestinal tract: I. Comparison of pHresponsive drug release and associated kinetics. Journal of Controlled Release, 1999; 59(2):229-242.
3. Nagata K, Takagi E, Tsuda M. Inhibitory action of Lansoprazole and its analogs against helicobacter pylori: inhibition of growth is not related to inhibition of urease. AntimicrobialAgents and Chemotherapy, 1995; 39:567-70.
4. Florence A. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharmaceutical Research, 1997; 14:259–266.
5. Ulrich K, Matthias S. Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease. Advanced Drug Delivery Review. 2005; 57(2):267-279.
6. Roy S, Das S.. Design and in-vitro evaluation of dapsone-loaded micropellets of ethyl cellulose. Pharmaceutical Research, 1989; 6(11):945-948.
7. DashevskyA, Kolter K, Bodmeier R. Compression of pellets coated with various aqueous polymer dispersions. International Journal of Pharmaceutics, 2004; 279:19–26.
8. Thassu D and Vyas SP. Drug Dev Ind Pharm. 1991; 17:561-576.
9. Wade A and Weller PJ. Handbook of Pharmaceutical Excipients. Washington, DC.American Pharmaceutical Publishing Association. 1994; 362-366.
10. Panigrahi L, Pattnaik S and Ghosal SK. AAPS PharmSciTech. 2005; 6:E167YE173.
11. Lym-Ly and Wan-LS, ‘Propranolol Binding in Calcium Alginate Beads’, Drug Develop. Indi. Pharm. 1997; 23(10):973- 980.
12. Manna A, Ghosh I, Goswami N, Ghosh LK.and Gupta BK. Design and evaluation of an oral controlled Release Microparticulate Drug Delivery system of Nimesulide by Ionotropic Gelation Technique and Statistical Optimization by Factorial Analysis, J Sci Ind.Res. 1999; 58(9):717-722.
13. Patil VB and Varsha B.Preparation and Evaluation of Sustained Release Nimesulide Microspheres prepared from sodium alginate’ Indian J Pharm Sci. 2001; 63(1):15-19.
14. David W. Fry, J. Courtland White, I. David Goldman Rapid separation of low molecular weight solutes from liposomes without dilution. Analytical Biochemistry 1978; 90(2):809-815.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).